|More on Biotech 14 Biotech Stocks Facing FDA Approval|
Answering viewers' Twitter questions, Jim Cramer warned investors off Sears and Delta, praised GE, and discussed whether Nike or Under Armour will gain more from the NBA Finals.
Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.
Trade-Ideas LLC identified Bio-Reference Laboratories (BRLI) as a "perilous reversal" (up big yesterday but down big today) candidate
Bio-Reference Labs (BRLI) shares are rising after the company agreed to be acquired by Opko Health (OPK) for $1.47 billion.